The Effect of a Navigator Nurse- Supported Mobile Application Developed Based on the IMB Model on the Quality of Life of Patients With Celiac Disease
NCT ID: NCT07177287
Last Updated: 2025-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-08-01
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of an Interactive Web-based Program in the Management of Multiple Sclerosis
NCT05393765
Mobile Application Effectiveness in Pressure Injury Care
NCT05255627
Effectiveness of Mobile Application-Supported Education and Counseling in Pregnant Women With Gestational Diabetes
NCT07318740
Effects of Information-Motivation-Behavioral Skills Model on Disease Management of Adolescents With Epilepsy
NCT06045520
Gamified Learning for Pressure Injury Prevention
NCT07028892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The IMB model provides a theoretical framework suggesting that health-related behaviors are influenced by information, motivation, and behavioral skills. A navigator nurse can support patients by providing education, motivation, and personalized guidance.
In this study, a mobile application was developed to provide education and continuous support to celiac patients under the guidance of a navigator nurse. The study hypothesizes that this intervention will improve health-related quality of life compared to standard clinical education.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: Navigator nurse-supported mobile application (IMB Model)
Participants receiving the navigator nurse-supported mobile application based on the IMB model.
IMB navigator app
Mobile application developed based on the IMB model, supported by a navigator nurse. Includes educational content, reminders and behavioral support. Patients will be followed for 6 months.
Control: Standard care without mobile application
Participants receiving standard care without the mobile application.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMB navigator app
Mobile application developed based on the IMB model, supported by a navigator nurse. Includes educational content, reminders and behavioral support. Patients will be followed for 6 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed with celiac disease
* Owning a smartphone and able to use the application
* Able to speak and understand Turkish
* Voluntary participation (informed consent)
* Withdrawal of consent during the study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Yildirim Beyazıt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İlknur Bodur
Research Nurse / MSN (Master of Science in Nursing)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hilal TÜZER
Role: STUDY_DIRECTOR
Faculty of Health Sciences, Ankara Yıldırım Beyazıt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Etlik City Hospital
Ankara, Ankara, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMB-CELIAC-QOL-2025-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.